Company intelligence / Profile preview

Euro Ossigeno

Ownership: Private
Development stage: Other

Overview

Euro Ossigeno operates a fully certified pharmaceutical department focused on the production, bottling, sale, and distribution of medicinal gases for hospital and home healthcare. The company holds all necessary authorizations from Italian regulatory bodies including AIFA. Its products are used in both liquid and gaseous forms for a range of clinical applications.

Therapeutic areas: PulmonologyOther
Modalities: Device (medical gases for therapeutic and diagnostic use)Small molecule (gaseous drugs such as oxygen, nitrous oxide)
Industry: Consumable Medical Devices

Beyond the preview

Go deeper on Euro Ossigeno.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Euro Ossigeno.

Explore the full profile